Preferred Label : dihydroergocryptine;

MeSH definition : A 9,10alpha-dihydro derivative of ERGOTAMINE that contains an isopropyl sidechain at the 2' position and an alpha-isobutyl sidechain at 5'alpha position of the molecule.;

CISMeF synonym : desitin brand of dihydroergocryptine monomesylate; hormosan brand of dihydroergocryptine monomesylate; taurus brand of dihydroergocryptine monomesylate;

MeSH hyponym : Dihydroergocryptine Monomesylate; almirid; Dihydroergocryptine Mesylate; cripar; Monomesylate, Dihydroergocryptine; Dihydroergokryptine Monomesylate; Monomesylate, Dihydroergokryptine; Mesylate, Dihydroergocryptine; Dihydroergokryptine Mesylate; Mesylate, Dihydroergokryptine;

MeSH CAS label : Ergotaman-3',6',18-trione, 9,10alpha-dihydro-12'-hydroxy-5'alpha-isobutyl-2'-isopropyl;

MeSH Related Number : dihydroergocryptine monomesylate; dihydroergocryptine mesylate; 14271-05-7 (Dihydroergocryptine monomesylate); 29261-93-6 (Dihydroergocryptine mesylate); 25447-66-9;

Registry Number MeSH : 25447-66-9;

Related CAS MeSH : 14271-05-7 (Dihydroergocryptine monomesylate); 29261-93-6 (Dihydroergocryptine mesylate);

Wikipedia link : https://en.wikipedia.org/wiki/Dihydroergocryptine mesylate;

Codes EINECS : 246-993-6;

Is substance : O;

UNII : 67V3FSL2GL;

Details


Main resources

You can consult :

A 9,10alpha-dihydro derivative of ERGOTAMINE that contains an isopropyl sidechain at the 2' position and an alpha-isobutyl sidechain at 5'alpha position of the molecule.

http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-11/vasobral_02-11-2011_avis_ct-11390.pdf
http://www.has-sante.fr/portail/jcms/c_1121579/vasobral
2011
France
French
evaluation of the transparency committee
Vasobral
treatment outcome
insurance, health, reimbursement
administration, oral
drug combinations
caffeine
other peripheral vasodilators
dihydroergocryptine
vasodilator agents
raynaud disease
cognition disorders
aged

---
http://www.has-sante.fr/portail/display.jsp?id=c_532481
2007
France
French
ergot alkaloids
administration, oral
pharmaceutical solutions
tablets
Vasobral
drug combinations
caffeine
dihydroergotoxine
insurance, health, reimbursement
aged
adult
raynaud disease
cognition disorders
dihydroergocryptine
evaluation of the transparency committee

---
Nous contacter.
23/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.